Jane Nixon is Professor of Tissue Viability and Clinical Trials Research and Deputy Director at the Institute of Clinical Trials Research. In 2016 she was appointed as an NIHR Senior Investigator and in 2017 was awarded an MBE for her contribution to health research. She gained a Masters in 1996 and PhD in 2001 whilst a senior nurse in the NHS, and moved to the University of Leeds and Deputy Director of the Clinical Trials Research Unit in 2002. Jane has had a longstanding career in clinical trials research, first as an NHS based Chief Investigator and since 2002 as Deputy Director of the Clinical Trials Research Unit.
In the pressure ulcer prevention field Jane has strong national and international collaborations and has undertaken two large multi-centre mattress trials, epidemiological research, systematic reviews of risk factors and quality of life, outcome measurement and instrument development has been involved/led sections of the international US National Pressure Ulcer advisory Panel/European Pressure Ulcer Advisory Panel pressure ulcer prevention guidelines.
Jane has 29 research and 8 infrastructure awards including: NIHR PURPOSE Programme (chief investigator, 10 clinical studies, 6735 patients); 3 large late phase trials – HTA PRESSURE 2 (chief investigator, 2030 patients), HTA PRESSURE (co-app, 1971 patients) and OR mattress (chief investigator, 466 patients. My research group works collaboratively with colleagues from dermatology, diabetes, surgery and tissue viability fields nationally and internationally and with the NIHR Clinical Research Network delivery teams.
Jane is past Chair and Treasurer of the Tissue Viability Society and Past President of the European Pressure ulcer Advisory Panel.